Versus beclomethasone dipropionate

Only one randomized, open-label clinical study comparing Alvesco® with beclomethasone dipropionate has been performed in adults with moderate-to-severe persistent asthma. The study found that Alvesco® improves morning peak expiratory flow (PEF) and asthmatic score significantly more than beclomethasone dipropionate.1

224 fig 1Versus beclomethasone  PEF Adachi 2007

Figure 1: Alvesco® 800 µg/day improves morning PEF significantly more than CFC-beclomethasone dipropionate 800 µg/day1

Reproduced with permission from Wiley & Sons.

224 fig 2Versus beclomethasone  asthmatic score Adachi 2007 adapted
Figure 2: Alvesco® 800 µg/day significantly improves asthmatic score compared with CFC-beclomethasone dipropionate 800 µg/day. Adapted from Adachi M, et al 2007.1 

  1. Adachi M, Ishihara K, Inoue H, et al. Efficacy and safety of inhaled ciclesonide compared with chlorofluorocarbon beclomethasone dipropionate in adults with moderate to severe persistent asthma. Respirology 2007;12:573-80.
Loading ...